145 related articles for article (PubMed ID: 21697218)
21. Sphingosine-1-phosphate restores endothelial barrier integrity in ovarian hyperstimulation syndrome.
Scotti L; Di Pietro M; Pascuali N; Irusta G; I de Zúñiga ; Gomez Peña M; Pomilio C; Saravia F; Tesone M; Abramovich D; Parborell F
Mol Hum Reprod; 2016 Dec; 22(12):852-866. PubMed ID: 27645281
[TBL] [Abstract][Full Text] [Related]
22. Preliminary proteomic analysis on the alterations in follicular fluid proteins from women undergoing natural cycles or controlled ovarian hyperstimulation.
Wu YT; Wu Y; Zhang JY; Hou NN; Liu AX; Pan JX; Lu JY; Sheng JZ; Huang HF
J Assist Reprod Genet; 2015 Mar; 32(3):417-27. PubMed ID: 25595538
[TBL] [Abstract][Full Text] [Related]
23. Elevated levels of interleukin-6 in the follicular fluid at the time of oocyte retrieval for in vitro fertilization may predict the development of early-form ovarian hyperstimulation syndrome.
Geva E; Lessing JB; Lerner-Geva L; Azem F; Yovel I; Amit A
Fertil Steril; 1997 Jul; 68(1):133-7. PubMed ID: 9207598
[TBL] [Abstract][Full Text] [Related]
24. [The Predictive Role of Vascular Endothelial Growth Factor and Estradiol in Infertile Patients with Ovarian Hyperstimulation Syndrome].
Wang Q; Yang G; Yang C; Zhan B; Yang R
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):565-7. PubMed ID: 12910723
[TBL] [Abstract][Full Text] [Related]
25. [Association between renin activity, angiotensin II and ovarian hyperstimulation syndrome].
Fan Y; Chen G
Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):647-50. PubMed ID: 11930686
[TBL] [Abstract][Full Text] [Related]
26. Is vascular endothelial growth factor (VEGF) the main mediator in ovarian hyperstimulation syndrome (OHSS)?
Ajonuma LC
Med Hypotheses; 2008; 70(6):1174-8. PubMed ID: 18164141
[TBL] [Abstract][Full Text] [Related]
27. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
Pau E; Alonso-Muriel I; Gómez R; Novella E; Ruiz A; García-Velasco JA; Simón C; Pellicer A
Hum Reprod; 2006 Jun; 21(6):1453-60. PubMed ID: 16488907
[TBL] [Abstract][Full Text] [Related]
28. Lipid Analysis of Follicular Fluids by UHPLC-ESI-HRMS Discovers Potential Biomarkers for Ovarian Hyperstimulation Syndrome.
Gao Y; Li J; Fan S; Chen P; Huang M; Bi H
Front Endocrinol (Lausanne); 2022; 13():895116. PubMed ID: 35846297
[TBL] [Abstract][Full Text] [Related]
29. Involvement of the ANGPTs/Tie-2 system in ovarian hyperstimulation syndrome (OHSS).
Scotti L; Abramovich D; Pascuali N; de Zúñiga I; Oubiña A; Kopcow L; Lange S; Owen G; Tesone M; Parborell F
Mol Cell Endocrinol; 2013 Jan; 365(2):223-30. PubMed ID: 23123737
[TBL] [Abstract][Full Text] [Related]
30. Ovarian hyperstimulation syndrome.
Avecillas JF; Falcone T; Arroliga AC
Crit Care Clin; 2004 Oct; 20(4):679-95, ix. PubMed ID: 15388196
[TBL] [Abstract][Full Text] [Related]
31. [Preliminary study on the role of vascular endothelial growth factor in pathogenesis of ovarian hyperstimulation syndrome].
Zhou C; Yu C; Zhuang G
Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):654-6. PubMed ID: 11930688
[TBL] [Abstract][Full Text] [Related]
32. Ovarian hyperstimulation syndrome prevention strategies: cryopreservation of all embryos.
D'Angelo A
Semin Reprod Med; 2010 Nov; 28(6):513-8. PubMed ID: 21082511
[TBL] [Abstract][Full Text] [Related]
33. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
[TBL] [Abstract][Full Text] [Related]
34. Comparative proteomic analysis of follicular fluids from normal and cystic follicles in sows.
Sun YL; Ping ZG; Li CJ; Sun YF; Yi KL; Chen L; Li XY; Wang XL; Zhou X
Reprod Domest Anim; 2011 Oct; 46(5):889-95. PubMed ID: 21366716
[TBL] [Abstract][Full Text] [Related]
35. Elevated serum müllerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization.
Nakhuda GS; Chu MC; Wang JG; Sauer MV; Lobo RA
Fertil Steril; 2006 May; 85(5):1541-3. PubMed ID: 16566934
[TBL] [Abstract][Full Text] [Related]
36. [Role of intercellular adhesion molecule-1 and E-selectin in the pathogenesis of ovarian hyperstimulation syndrome].
Kovachev E; Kozovski I; Markova V; Gemer O; Cherneva S
Akush Ginekol (Sofiia); 2005; 44(4):26-31. PubMed ID: 16028375
[TBL] [Abstract][Full Text] [Related]
37. Risk Factors and Methods for Predicting Ovarian Hyperstimulation Syndrome (OHSS) in the in vitro Fertilization.
Pakhomov SP; Orlova VS; Verzilina IN; Sukhih NV; Nagorniy AV; Matrosova AV
Arch Razi Inst; 2021 Nov; 76(5):1461-1468. PubMed ID: 35355759
[TBL] [Abstract][Full Text] [Related]
38. Unpredictable cases of complicated ovarian hyperstimulation in IVF.
Delvigne A; Vandromme J; Demeestere I; Leroy F
Int J Fertil Womens Med; 1997; 42(4):268-70. PubMed ID: 9309462
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of angiopoietin-1 (ANGPT1) affects vascular integrity in ovarian hyperstimulation syndrome (OHSS).
Scotti L; Abramovich D; Pascuali N; Durand LH; Irusta G; de Zúñiga I; Tesone M; Parborell F
Reprod Fertil Dev; 2016 Apr; 28(6):690-9. PubMed ID: 25485810
[TBL] [Abstract][Full Text] [Related]
40. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
Zhu WJ; Li XM; Chen XM; Zhang L
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
